The Bird Flu is marching on and becoming an increasing threat as the H5N1 human strain is in Africa causing issues now. Producing enough vaccine fast enough just is not an option if the strain evolves of mutates to flow quickly like Influenza from human to human. One recent article in the Boston Globe accuses Rouche Pharmaceuticals of predatory price strategies for buying up all the Star Anise Fruit Crop a potential component of the TamiFlu vaccine.

If we enlist our Federal Trade Commission to go after them for anti-trust violations when the governments, EU and World Wide Patent laws created this situation in the first place then we put all businesses at a catch 22; in that why bother producing if you are simply going to be attacked? Why make a vaccine in huge quantities? Simply make enough for your self, let the peanut gallery go die of Bird Flu or whatever and screw it? Because this is what will happen if you attack Rouche.

Buying 2 Billion in stockpile for a Bird Flu, which may never come is a power play of which the anti-trust issues the article brings up do not address. If we do not buy some of Rouche